Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | 2 Months Ended | 3 Months Ended | 4 Months Ended | 5 Months Ended | 7 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 12, 2021 |
Oct. 12, 2020 |
Aug. 28, 2020 |
Jun. 11, 2021 |
Aug. 27, 2020 |
Jul. 31, 2021 |
Jul. 31, 2021 |
Oct. 31, 2020 |
Oct. 31, 2021 |
Apr. 30, 2021 |
Oct. 31, 2020 |
Jul. 31, 2020 |
Apr. 30, 2020 |
Jun. 11, 2021 |
Oct. 31, 2021 |
Aug. 27, 2020 |
Oct. 31, 2020 |
Jan. 31, 2021 |
Jan. 31, 2020 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||||||
| Common stock issued | 4,000,000 | ||||||||||||||||||
| Number of warrants to purchase additional common shares | 705,882 | ||||||||||||||||||
| Common shares authorized | 1,000,000,000 | ||||||||||||||||||
| Preferred shares authorized | 10,000,000 | 10,000,000 | |||||||||||||||||
| Common stock par value | $ 0.0001 | $ 0.0001 | $ 0.01 | ||||||||||||||||
| Common stock shares outstanding | 4,000,000 | ||||||||||||||||||
| Fair value adjustment of warrants | $ 7,400 | $ (2,900) | $ 36,838 | $ (900) | $ 19,723 | ||||||||||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Predecessor | Predecessor | Predecessor | Successor | Successor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor | |
| Class A Common Stock | |||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||||||
| Common stock issued | 133,164,526 | 133,164,526 | 3,840,000 | ||||||||||||||||
| Common shares authorized | 375,000,000 | 375,000,000 | 800,000,000 | ||||||||||||||||
| Common stock par value | $ 0.0001 | $ 0.0001 | |||||||||||||||||
| Common stock shares outstanding | 133,164,526 | 133,164,526 | 3,840,000 | ||||||||||||||||
| Increase (decrease) in earnings attributable to common stockholders | (5,900) | ||||||||||||||||||
| Class B Common Stock | |||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||||||
| Common stock issued | 160,000 | ||||||||||||||||||
| Common shares authorized | 200,000,000 | ||||||||||||||||||
| Common stock shares outstanding | 160,000 | ||||||||||||||||||
| Net increase in value of participation rights | 13,300 | ||||||||||||||||||
| Increase (decrease) in earnings attributable to common stockholders | $ 5,900 | ||||||||||||||||||
| Class C Common Stock | |||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||||||
| Common shares authorized | 3,840,000 | 3,840,000 | |||||||||||||||||